bimatoprost ophthalmic insert (Pending FDA Approval)

Brand and Other Names:
  • Print

Dosing & Uses

Open-Angle Glaucoma or Ocular Hypertension

Pending FDA approval to lower intraocular pressure (IOP) for patients with open-angle glaucoma or ocular hypertension

Next:

Pharmacology

Mechanism of Action

Sustained-release, biodegradable intraocular implant

Prostaglandin analog; increases outflow of aqueous humor

Previous
Next:

Images

Previous
Next:
Medscape prescription drug monographs are based on FDA-approved labeling information, unless otherwise noted, combined with additional data derived from primary medical literature.